North America Breast Cancer Brachytherapy Market Size & Outlook
Related Markets
North America breast cancer brachytherapy market highlights
- The North America breast cancer brachytherapy market generated a revenue of USD 444.8 million in 2024.
- The market is expected to grow at a CAGR of 6% from 2025 to 2030.
- In terms of segment, high dose rate (hdr) was the largest revenue generating technology in 2024.
- High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 444.8 million |
| Market revenue in 2030 | USD 632.8 million |
| Growth rate | 6% (CAGR from 2025 to 2030) |
| Largest segment | High dose rate (hdr) |
| Fastest growing segment | High Dose Rate (HDR) |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High Dose Rate (HDR), Low Dose Rate (LDR) |
| Key market players worldwide | Eckert & Ziegler Bebig SA, Elekta AB ADR, Siemens Healthineers AG ADR, Icad Inc, Hologic Inc, Merit Medical Systems Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 49.6% of the global breast cancer brachytherapy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 279.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Brachytherapy Market Scope
Breast Cancer Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eckert & Ziegler Bebig SA | View profile | 501-1000 | Seneffe, Hainaut, Belgium, Europe | http://www.ezag.com/home/ |
| Merit Medical Systems Inc | View profile | 6950 | 1600 West Merit Parkway, South Jordan, UT, United States, 84095 | https://www.merit.com |
| Icad Inc | View profile | 69 | 98 Spit Brook Road, Suite 100, Nashua, NH, United States, 03062 | https://www.icadmed.com |
| Elekta AB ADR | View profile | 4584 | Kungstensgatan 18, Box 7593, Stockholm, Sweden, SE-103 93 | https://www.elekta.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
North America breast cancer brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.
High dose rate (hdr) was the largest segment with a revenue share of 72.03% in 2024. Horizon Databook has segmented the North America breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America breast cancer brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America breast cancer brachytherapy market databook
-
Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America breast cancer brachytherapy market, including forecasts for subscribers. This continent databook contains high-level insights into North America breast cancer brachytherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America breast cancer brachytherapy market size, by country, 2018-2030 (US$M)
North America Breast Cancer Brachytherapy Market Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
